Dapsone 8.5% / Niacinamide 2% / Spironolactone 5%
Product Images NDC 72934-1064

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Dapsone 8.5% / Niacinamide 2% / Spironolactone 5% (NDC 72934-1064). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sincerus Florida, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

De (2 End)

FDA Label Image

A (1064 2 Front)

FDA Label Image

Dw (1064 2 Middle)

Dw (1064 2 Middle)
This is a medication with active ingredients such as Bapsone USP, Niacinamide USP, and Spironolactone USP mainly used for treating severe acne. It also has inactive ingredients such as Lavender oil, Polyethylene glycol USP, and, Suspenissee Gl.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.